Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01270633 · ClinicalTrials.gov registry record · NA
A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers
A NA study, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01270633 is a NA study that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 30 participants.
The verdict
NCT01270633, a NA study, was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical and economic effectiveness of PriMatrix and Standard of Care in the treatment of diabetic foot ulcers (DFUs) in subjects with controlled diabetes mellitus and without significantly compromised arterial circulation.
Interventions
- OTHER Standard of Care
- DEVICE PriMatrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-12 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01270633
The ClinicalTrials.gov registry entry for NCT01270633 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT01270633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01270633 about?
NCT01270633 is a clinical study titled "A Study With Primatrix Dermal Repair Scaffold For The Treatment Of Diabetic Foot Ulcers". The purpose of this study is to compare the clinical and economic effectiveness of PriMatrix and Standard of Care in the treatment of diabetic foot ulcers (DFUs) in subjects with controlled diabetes mellitus and without significantly compromised arterial circulation.
What is the current status of trial NCT01270633?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2010-12. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01270633?
The interventions under investigation include: Standard of Care (OTHER), PriMatrix (DEVICE).
Who is sponsoring clinical trial NCT01270633?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.